Synthetic plasmodium antigens, compositions, and uses thereof

US11787845B1 · kind B1 · utility

Assignees

• University of South Florida · US
• Washington University · US
• CASE WESTERN RESERVE UNIVERSITY · US

Inventors

• John H. Adams · Tampa, US
• Christopher L. King · Moreland Hills, US
• Niraj H. Tolia · Chesterfield, US
• Edwin Chen · Chesterfield, US
• Nichole Diane Salinas · Chesterfield, US
• Miriam Thankam George · Nilgrar, IN
• Francis B. Ntumngia · Tampa, US
• Samantha Jones Barnes · Tampa, US

Key dates

• Filing date: Nov 24, 2020
• Grant date: Oct 17, 2023
• Expiry date: Jun 5, 2041

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are synthetic P. vivax antigens, antibodies and pharmaceutical formulations and vaccines thereof. Also provided herein are methods of treating and/or preventing Plasmodium infection and/or disease by administering the synthetic P. vivax antigens, antibodies and pharmaceutical formulations and vaccines thereof.